A systematic review of the literature for severity predictors in children with sickle cell anemia

Blood Cells, Molecules, and Diseases

Volumn 65, Issue , 2017, Pages 86-94

  Meier, Emily Riehm ^a   Fasano, Ross M ^b   Levett, Paul R ^c  

^a INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Alpha thalassemia; Fetal hemoglobin; Reticulocyte; Sickle cell anemia; Transcranial Doppler

Indexed keywords

HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN F; HYDROXYUREA; BIOLOGICAL MARKER; HEMOGLOBIN BETA CHAIN;

ALPHA GLOBIN GENE; ALPHA THALASSEMIA; ARTICLE; BIOLOGICAL TRAIT; BRAIN INFARCTION; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; GENE NUMBER; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETICULOCYTE COUNT; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; VALIDATION STUDY; BLOOD; GENETICS; METABOLISM; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ALPHA-GLOBINS; ANEMIA, SICKLE CELL; BETA-GLOBINS; BIOMARKERS; CHILD; FETAL HEMOGLOBIN; HUMANS; PROGNOSIS; RETICULOCYTE COUNT; SEVERITY OF ILLNESS INDEX;

EID: 85011592558     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2017.01.014     Document Type: Article

References (68)

1. Walters, M.C., Patience, M., Leisenring, W., Eckman, J.R., Scott, J.P., Mentzer, W.C., Davies, S.C., Ohene-Frempong, K., Bernaudin, F., Matthews, D.C., Storb, R., Sullivan, K.M., Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335 (1996), 369–376.
2. Shenoy, S., Has stem cell transplantation come of age in the treatment of sickle cell disease?. Bone Marrow Transplant. 40 (2007), 813–821.
3. Arnold, S.D., Bhatia, M., Horan, J., Krishnamurti, L., Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches. Br. J. Haematol. 174 (2016), 515–525.
4. Miller, S.T., Sleeper, L.A., Pegelow, C.H., Enos, L.E., Wang, W.C., Weiner, S.J., Wethers, D.L., Smith, J., Kinney, T.R., Prediction of adverse outcomes in children with sickle cell disease. N. Engl. J. Med. 342 (2000), 83–89.
5. Quinn, C.T., Lee, N.J., Shull, E.P., Ahmad, N., Rogers, Z.R., Buchanan, G.R., Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. Blood 111 (2008), 544–548.
6. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P., Bonds, D.R., Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N. Engl. J. Med. 332 (1995), 1317–1322.
7. Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Waclawiw, M.A., Huang, X., Thompson, B.W., Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet (London, England) 377 (2011), 1663–1672.
8. Thornburg, C.D., Files, B.A., Luo, Z., Miller, S.T., Kalpatthi, R., Iyer, R., Seaman, P., Lebensburger, J., Alvarez, O., Thompson, B., Ware, R.E., Wang, W.C., Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood 120 (2012), 4304–4310 (quiz 4448).
9. Yawn, B.P., Buchanan, G.R., Afenyi-Annan, A.N., Ballas, S.K., Hassell, K.L., James, A.H., Jordan, L., Lanzkron, S.M., Lottenberg, R., Savage, W.J., Tanabe, P.J., Ware, R.E., Murad, M.H., Goldsmith, J.C., Ortiz, E., Fulwood, R., Horton, A., John-Sowah, J., Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312 (2014), 1033–1048.
10. Thompson, A.A., Primary prophylaxis in sickle cell disease: is it feasible? Is it effective?. Hematology Am. Soc. Hematol. Educ. Program 2011 (2011), 434–439.
11. Nickel, R.S., Hendrickson, J.E., Haight, A.E., The ethics of a proposed study of hematopoietic stem cell transplant for children with “less severe” sickle cell disease. Blood 124 (2014), 861–866.
12. Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med., 6, 2009, e1000100.
13. King, A., Shenoy, S., Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia. Blood 123 (2014), 3089–3094 (quiz 3210).
14. Adams, R.J., Brambilla, D.J., Granger, S., Gallagher, D., Vichinsky, E., Abboud, M.R., Pegelow, C.H., Woods, G., Rohde, E.M., Nichols, F.T., Jones, A., Luden, J.P., Bowman, L., Hagner, S., Morales, K.H., Roach, E.S., Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood 103 (2004), 3689–3694.
15. Benson, J.M., Therrell, B.L. Jr., History and current status of newborn screening for hemoglobinopathies. Semin. Perinatol. 34 (2010), 134–144.
16. Badr, A.K., Hassan, M.K., The influence of fetal hemoglobin on clinical and hematological variables of children and adolescents with sickle cell anemia in Basra, Southern Iraq. Iranian J. Blood Cancer 7 (2015), 179–183.
17. Bailey, K., Morris, J.S., Thomas, P., Serjeant, G.R., Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch. Dis. Child. 67 (1992), 517–520.
18. Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M., Delacourt, C., G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 112 (2008), 4314–4317.
19. Bhatnagar, P., Keefer, J.R., Casella, J.F., Barron-Casella, E.A., Bean, C.J., Hooper, C.W., Payne, A.B., Arking, D.E., Debaun, M.R., Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia. Pediatr. Blood Cancer 60 (2013), E125–E127.
20. DeBaun, M.R., Sarnaik, S.A., Rodeghier, M.J., Minniti, C.P., Howard, T.H., Iyer, R.V., Inusa, B., Telfer, P.T., Kirby-Allen, M., Quinn, C.T., Bernaudin, F., Airewele, G., Woods, G.M., Panepinto, J.A., Fuh, B., Kwiatkowski, J.K., King, A.A., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding-Lallinger, R.C., Kirkham, F.J., Sabio, H., Gonzalez, C.E., Saccente, S.L., Kalinyak, K.A., Strouse, J.J., Fixler, J.M., Gordon, M.O., Miller, J.P., Noetzel, M.J., Ichord, R.N., Casella, J.F., Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood 119 (2012), 3684–3690.
21. Kinney, T.R., Sleeper, L.A., Wang, W.C., Zimmerman, R.A., Pegelow, C.H., Ohene-Frempong, K., Wethers, D.L., Bello, J.A., Vichinsky, E.P., Moser, F.G., Gallagher, D.M., DeBaun, M.R., Platt, O.S., Miller, S.T., Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 103 (1999), 640–645.
22. Odenheimer, D.J., Sarnaik, S.A., Whitten, C.F., Rucknagel, D.L., Sing, C.F., The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia. Am. J. Med. Genet. 27 (1987), 525–535.
23. Sheehan, V.A., Luo, Z., Flanagan, J.M., Howard, T.A., Thompson, B.W., Wang, W.C., Kutlar, A., Ware, R.E., Investigators, B.H., Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am. J. Hematol. 88 (2013), 571–576.
24. Silva, I.V., Reis, A.F., Palare, M.J., Ferrao, A., Rodrigues, T., Morais, A., Sickle cell disease in children: chronic complications and search of predictive factors for adverse outcomes. Eur. J. Haematol. 94 (2015), 157–161.
25. Stevens, M.C., Hayes, R.J., Vaidya, S., Serjeant, G.R., Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood. J. Pediatr. 98 (1981), 37–41.
26. Thomas, P.W., Higgs, D.R., Serjeant, G.R., Benign clinical course in homozygous sickle cell disease: a search for predictors. J. Clin. Epidemiol. 50 (1997), 121–126.
27. Thein, S.L., Menzel, S., Lathrop, M., Garner, C., Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum. Mol. Genet. 18 (2009), R216–R223.
28. Adams, R.J., Kutlar, A., McKie, V., Carl, E., Nichols, F.T., Liu, J.C., McKie, K., Clary, A., Alpha thalassemia and stroke risk in sickle cell anemia. Am. J. Hematol. 45 (1994), 279–282.
29. Belisario, A.R., Rodrigues, C.V., Martins, M.L., Silva, C.M., Viana, M.B., Coinheritance of alpha-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia. Hemoglobin 34 (2010), 516–529.
30. Cajado, C., Cerqueira, B.A., Couto, F.D., Moura-Neto, J.P., Vilas-Boas, W., Dorea, M.J., Lyra, I.M., Barbosa, C.G., Reis, M.G., Goncalves, M.S., TNF-alpha and IL-8: serum levels and gene polymorphisms (− 308G > A and − 251A > T) are associated with classical biomarkers and medical history in children with sickle cell anemia. Cytokine 56 (2011), 312–317.
31. Filho, I.L., Leite, A.C., Moura, P.G., Ribeiro, G.S., Cavalcante, A.C., Azevedo, F.C., Andrada-Serpa, M.J., Genetic polymorphisms and cerebrovascular disease in children with sickle cell anemia from Rio de Janeiro, Brazil. Arq. Neuropsiquiatr. 69 (2011), 431–435.
32. Flanagan, J.M., Frohlich, D.M., Howard, T.A., Schultz, W.H., Driscoll, C., Nagasubramanian, R., Mortier, N.A., Kimble, A.C., Aygun, B., Adams, R.J., Helms, R.W., Ware, R.E., Genetic predictors for stroke in children with sickle cell anemia. Blood 117 (2011), 6681–6684.
33. Hsu, L.L., Miller, S.T., Wright, E., Kutlar, A., McKie, V., Wang, W., Pegelow, C.H., Driscoll, C., Hurlet, A., Woods, G., Elsas, L., Embury, S., Adams, R.J., T. Stroke Prevention D, The Cooperative Study of Sickle Cell, alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J. Pediatr. Hematol. Oncol. 25 (2003), 622–628.
34. Joly, P., Garnier, N., Kebaili, K., Renoux, C., Dony, A., Cheikh, N., Renard, C., Ceraulo, A., Cuzzubbo, D., Pondarre, C., Martin, C., Pialoux, V., Francina, A., Bertrand, Y., Connes, P., G6PD deficiency and absence of alpha-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia. Eur. J. Haematol. 96 (2016), 404–408.
35. Sarnaik, S.A., Ballas, S.K., Molecular characteristics of pediatric patients with sickle cell anemia and stroke. Am. J. Hematol. 67 (2001), 179–182.
36. Thangarajh, M., Yang, G., Fuchs, D., Ponisio, M.R., McKinstry, R.C., Jaju, A., Noetzel, M.J., Casella, J.F., Barron-Casella, E., Hooper, W.C., Boulet, S.L., Bean, C.J., Pyle, M.E., Payne, A.B., Driggers, J., Trau, H.A., Vendt, B.A., Rodeghier, M., DeBaun, M.R., Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. Br. J. Haematol. 159 (2012), 352–359.
37. Belisário, A.R., Martins, M.L., Brito, A.M.S., Rodrigues, C.V., Silva, C.M., Viana, M.B., β-Globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or Sβ-thalassemia and their association with clinical and hematological features. Acta Haematol. 124 (2010), 162–170.
38. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coic, L., Leveille, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galacteros, F., Torres, M., Kuentz, M., Ferry, C., Socie, G., Reinert, P., Delacourt, C., Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 117 (2011), 1130–1140 (quiz 1436).
39. Meier, E.R., Byrnes, C., Lee, Y.T., Wright, E.C., Schechter, A.N., Luban, N.L., Miller, J.L., Increased reticulocytosis during infancy is associated with increased hospitalizations in sickle cell anemia patients during the first three years of life. PLoS One, 8, 2013, e70794.
40. Meier, E.R., Wright, E.C., Miller, J.L., Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease. Am. J. Hematol. 89 (2014), 904–906.
41. Silva, C.M., Giovani, P., Viana, M.B., High reticulocyte count is an independent risk factor for cerebrovascular disease in children with sickle cell anemia. Pediatr. Blood Cancer 56 (2011), 116–121.
42. Adams, R.J., McKie, V.C., Carl, E.M., Nichols, F.T., Perry, R., Brock, K., McKie, K., Figueroa, R., Litaker, M., Weiner, S., Brambilla, D., Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann. Neurol. 42 (1997), 699–704.
43. Boyd, J.H., Macklin, E.A., Strunk, R.C., DeBaun, M.R., Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 108 (2006), 2923–2927.
44. Field, J.J., Macklin, E.A., Yan, Y., Strunk, R.C., DeBaun, M.R., Sibling history of asthma is a risk factor for pain in children with sickle cell anemia. Am. J. Hematol. 83 (2008), 855–857.
45. Uong, E.C., Boyd, J.H., DeBaun, M.R., Daytime pulse oximeter measurements do not predict incidence of pain and acute chest syndrome episodes in sickle cell anemia. J. Pediatr. 149 (2006), 707–709.
46. Carpenter, S.L., Lieff, S., Howard, T.A., Eggleston, B., Ware, R.E., UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Am. J. Hematol. 83 (2008), 800–803.
47. Hoppe, C., Klitz, W., Cheng, S., Apple, R., Steiner, L., Robles, L., Girard, T., Vichinsky, E., Styles, L., Investigators, C., Gene interactions and stroke risk in children with sickle cell anemia. Blood 103 (2004), 2391–2396.
48. Hoppe, C., Cheng, S., Grow, M., Silbergleit, A., Klitz, W., Trachtenberg, E., Erlich, H., Vichinsky, E., Styles, L., A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br. J. Haematol. 114 (2001), 718–720.
49. Hoppe, C., Klitz, W., D'Harlingue, K., Cheng, S., Grow, M., Steiner, L., Noble, J., Adams, R., Styles, L., I. Stroke prevention trial in sickle cell anemia, confirmation of an association between the TNF(− 308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke 38 (2007), 2241–2246.
50. Hyacinth, H.I., Gee, B.E., Adamkiewicz, T.V., Adams, R.J., Kutlar, A., Stiles, J.K., Hibbert, J.M., Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia. Cytokine 60 (2012), 302–308.
51. DeBaun, M.R., Rodeghier, M., Cohen, R., Kirkham, F.J., Rosen, C.L., Roberts, I., Cooper, B., Stocks, J., Wilkey, O., Inusa, B., Warner, J.O., Strunk, R.C., Factors predicting future ACS episodes in children with sickle cell anemia. Am. J. Hematol. 89 (2014), E212–E217.
52. Quinn, C.T., Variste, J., Dowling, M.M., Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia. Br. J. Haematol. 145 (2009), 500–505.
53. Vance, L.D., Rodeghier, M., Cohen, R.T., Rosen, C.L., Kirkham, F.J., Strunk, R.C., DeBaun, M.R., Increased risk of severe vaso-occlusive episodes after initial acute chest syndrome in children with sickle cell anemia < 4 years old: sleep and asthma cohort. Am. J. Hematol. 90 (2015), 371–375.
54. Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., Hess, D., The use of transcranial ultrasonography to predict stroke in sickle cell disease. N. Engl. J. Med. 326 (1992), 605–610.
55. Adams, R.J., McKie, V.C., Brambilla, D., Carl, E., Gallagher, D., Nichols, F.T., Roach, S., Abboud, M., Berman, B., Driscoll, C., Files, B., Hsu, L., Hurlet, A., Miller, S., Olivieri, N., Pegelow, C., Scher, C., Vichinsky, E., Wang, W., Woods, G., Kutlar, A., Wright, E., Hagner, S., Tighe, F., Waclawiw, M.A., Stroke prevention trial in sickle cell anemia. Control. Clin. Trials 19 (1998), 110–129.
56. Kwiatkowski, J.L., Granger, S., Brambilla, D.J., Brown, R.C., Miller, S.T., Adams, R.J., Investigators, S.T., Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br. J. Haematol. 134 (2006), 333–339.
57. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H., Klug, P.P., Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330 (1994), 1639–1644.
58. Noguchi, C.T., Rodgers, G.P., Serjeant, G., Schechter, A.N., Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N. Engl. J. Med. 318 (1988), 96–99.
59. Meier, E.R., Byrnes, C., Weissman, M., Noel, P., Luban, N.L., Miller, J.L., Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood. Pediatr. Blood Cancer 56 (2011), 103–109.
60. Wang, W.C., Pavlakis, S.G., Helton, K.J., McKinstry, R.C., Casella, J.F., Adams, R.J., Rees, R.C., MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr. Blood Cancer 51 (2008), 643–646.
61. Duckett, J.R., Constantine, G., The Kleihauer technique: an accurate method of quantifying fetomaternal haemorrhage?. Br. J. Obstet. Gynaecol. 104 (1997), 845–846.
62. Chen, J.C., Davis, B.H., Wood, B., Warzynski, M.J., Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytometry 50 (2002), 285–290.
63. DeBaun, M.R., Gordon, M., McKinstry, R.C., Noetzel, M.J., White, D.A., Sarnaik, S.A., Meier, E.R., Howard, T.H., Majumdar, S., Inusa, B.P., Telfer, P.T., Kirby-Allen, M., McCavit, T.L., Kamdem, A., Airewele, G., Woods, G.M., Berman, B., Panepinto, J.A., Fuh, B.R., Kwiatkowski, J.L., King, A.A., Fixler, J.M., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding-Lallinger, R.C., Kirkham, F.J., Dixon, N., Gonzalez, C.E., Kalinyak, K.A., Quinn, C.T., Strouse, J.J., Miller, J.P., Lehmann, H., Kraut, M.A., Ball, W.S. Jr., Hirtz, D., Casella, J.F., Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N. Engl. J. Med. 371 (2014), 699–710.
64. Boyd, J.H., Macklin, E.A., Strunk, R.C., DeBaun, M.R., Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica 92 (2007), 1115–1118.
65. Lettre, G., The search for genetic modifiers of disease severity in the beta-hemoglobinopathies. Cold Spring Harb. Perspect. Med., 2, 2012.
66. National Heart Lung and Blood Institute (NHLBI), Evidence-based Management of Sickle Cell Disease: Expert Panel Report, 2014. 2014 (http://www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines).
67. Ware, R.E., Davis, B.R., Schultz, W.H., Brown, R.C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., Luchtman-Jones, L., Rogers, Z.R., Hilliard, L., Gauger, C., Piccone, C., Lee, M.T., Kwiatkowski, J.L., Jackson, S., Miller, S.T., Roberts, C., Heeney, M.M., Kalfa, T.A., Nelson, S., Imran, H., Nottage, K., Alvarez, O., Rhodes, M., Thompson, A.A., Rothman, J.A., Helton, K.J., Roberts, D., Coleman, J., Bonner, M.J., Kutlar, A., Patel, N., Wood, J., Piller, L., Wei, P., Luden, J., Mortier, N.A., Stuber, S.E., Luban, N.L., Cohen, A.R., Pressel, S., Adams, R.J., Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet (London, England) 387 (2016), 661–670.
68. Quinn, C.T., Rogers, Z.R., McCavit, T.L., Buchanan, G.R., Improved survival of children and adolescents with sickle cell disease. Blood 115 (2010), 3447–3452.